Adolescent Treatment Compliance in Asthma

Royal Pharmaceutical Society of Great Britain. From Compliance to Concordance: Achieving Shared Goals in Medicine Taking. London: RPS 1997

Chambers C.V. , Markson L. , Diamond J.J. , Lasch L. , Berger M. Health beliefs and compliance with inhaled corticosteroids by asthmatic patients in primary care practices. Resp Med 1999; 93: 88–94

Lim S.H. , Goh D.Y. , Tan A.Y. , Lee BW. Parents’ perceptions towards the child's use of inhaled medications for asthma therapy. J Paediatr Child Health 1996; 32: 306–9

Boulet LP. Perception of the role and potential side effects of inhaled corticosteroids among asthmatic patients. Chest 1998; 113: 587–92

Buston K.M. , Wood SF. Noncompliance amongst adolescents with asthma: listening to what they tell us about self-management. Fam Pract 2000; 17: 134–8

Jonasson G. , Carlsen K.H. , Sodal A. , Jonasson C. , Mowinckel P. Patient compliance in a clinical trial with inhaled budesonide in children with mild asthma. Europ Resp J 1999; 14: 150–4

Kyngas HA. Compliance of adolescents with asthma. Nurs Health Sci 1999; 1: 195–201

Bryon M. Adherence to treatment in children. In: Midence K. , ed. Adherence to Treatment in Medical Conditions. London: Harwood Academic, 1996; 161–89

Coutts J.A. , Gibson N.A. , Paton JY. Measuring compliance with inhaled medication in asthma. Arch Dis Child 1992; 67: 332–3

Department of Health. Prescriptions dispensed in the community: statistics for 1989 to 1999: England. Statist Bull 2000/20

Bender B. , Milgrom H. , Rand C. , Ackerson L. Psychological factors associated with medication nonadherence in asthmatic children. J Asthma 1998; 35: 347–53

Spector S. Noncompliance with asthma therapy—are there solutions? J Asthma 2000; 37: 381–8

Milgrom H. , Bender B. , Ackerson L. , Bowry P. , Smith B. , Rand C. Noncompliance and treatment failure in children with asthma. J Allergy Clin Immunol 1996; 98: 1051–7

Put C. , Van den Bergh O. , Demedts M. , Verleden G. A study of the relationship among self-reported noncompliance, symptomatology, and psychological variables in patients with asthma. J Asthma 2000; 37: 503–10

Sherman J. , Hutson A. , Baumstein S. , Hendeles L. Telephoning the patient's pharmacy to assess adherence with asthma medications by measuring refill rate for prescriptions. J Pediatr 2000; 136: 532–6

Mushlin A.I. , Appel FA. Diagnosing potential noncompliance. Physicians’ ability in a behavioral dimension of medical care. Arch Intern Med 1997; 137: 318–21

Chung K.F. , Naya I. Compliance with an oral asthma medication: a pilot study using an electronic monitoring device. Resp Med 2000; 94: 852–8

Kossoy A.F. , Hill M. , Lin F.L. , Szefler SJ. Are theophylline “levels” a reliable indicator of compliance? J Allergy Clin Immunol 1989; 84: 60–5

Parameswaran K. , Leigh R. , Hargreave FE. Sputum eosinophil count to assess compliance with corticosteroid therapy in asthma. J Allergy Clin Immunol 1999; 104: 502–3

Levine RJ. Monitoring for adherence: ethical considerations. Am J Resp Crit Care Med 1994; 149: 287–8

Sackett DL. The magnitude of compliance and noncompliance. In: Sackett D.L. , Hughes R.B. , eds. Compliance with Therapeutic Regimes. Baltimore: Johns Hopkins University Press, 1976

Cochrane M. Addressing the problem of noncompliance. Resp Dis Pract 1999; 16: 17–19

Redline S. , Wright E.C. , Kattan M. , Keresmar C. , Weiss K. Short-term compliance with peak flow monitoring: results from a study of inner city children with asthma. Pediat Pulmonol 1996; 21: 203–10

Chowienczyk P.J. , Parkin D.H. , Lawson C.P. , Cochrane GM. Do asthmatic patients correctly record home spirometry measurements? BMJ 1994; 309: 1618

Balsbaugh T.A. , Chambers C.V. , Diamond JJ. Asthma controller medications: what do patients want? J Asthma 1999; 36: 591–6

Weinberg E.G. , Naya I. Treatment preferences of adolescent patients with asthma. Pediatr Allergy Immunol 2000; 11: 49–55

Ng D.K. , Lee V. , Ho JC. Comparison of preference and ease-of-use of breath-actuated inhalation devices in children. Respirology 1999; 4: 255–7

Pieters W.R. , Stallaert R.A. , Prins J. A study on the clinical equivalence and patient preference of fluticasone propionate 250 microgram twice daily via the Diskus/Accuhaler inhaler or the Diskhaler inhaler in adult asthmatic patients. J Asthma 1998; 35: 337–45

van der Palen J. , Klein J.J. , Schildkamp AM. Comparison of a new multidose powder inhaler (Diskus/Accuhaler) and the Turbuhaler regarding preference and ease of use. J Asthma 1998; 35: 147–52

Haynes R.B. , Montague P. , Oliver T. , McKibbon K.A. , Brouwers M.C. , Kanani R. Interventions for helping patients to follow prescriptions for medications (Cochrane Review). In: The Cochrane Library Issue 4, 2001. Oxford: Update Software

Venables T.L. , Addlestone M.B. , Smithers A.J. A comparison of the efficacy and patient acceptability of once daily budesonide via Turbohaler and twice daily fluticasone propionate via disc-inhaler at an equal daily dose of 400 μg in adult asthmatics. Br J Clin Res 1996; 7: 15–32

Möller C. , Strömberg L. , Oldaeus G. , Arweström E. , Kjellman M. Eficacy of once-daily versus twice-daily administration of budesonide by Turbuhaler(R) in children with stable asthma. Pediatr Pulmonol 1999; 28: 337–43

ZuWallack R. , Adelglass J. , Clifford D.P. Long-term efficacy and safety of fluticasone propionate powder administered once or twice daily via inhaler to patients with moderate asthma. Chest 2000; 118: 303–12

McDonald C. , Pover G.M. , Crompton GK. Evaluation of the combination inhaler of salbutamol and beclomethasone dipropionate in the management of asthma. Curr Med Res Opin 1988; 11: 116–22

Barnes P.J. , O'Connor BJ. Use of a fixed combination beta 2-agonist and steroid dry powder inhaler in asthma. Am J Resp Crit Care Med 1995; 151: 1053–7

Van den Berg N.J. , Ossip M.S. , Hederos C.A. , Anttila H. , Ribeiro B.L. , Davies PI. Salmeterol/fluticasone propionate (50/100 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in children with asthma. Pediatr Pulmonol 2000; 30: 97–105

Bosley C.M. , Parry D.T. , Cochrane GM. Patient compliance with inhaled medication: does combining beta-agonists with corticosteroids improve compliance? Europ Resp J 1994; 7: 504–9

Jonasson G. , Carlsen K.H. , Mowinckel P. Asthma drug adherence in a long term clinical trial. Arch Dis Child 2000; 83: 330–3

Walker S.A. , Avis M. Common reasons why peer education fails. J Adolescence 1999; 22: 573–7

Fosarelli P. , DeAngelois C. , Kaszuba A. Compliance with follow-up appointments generated in a pediatric emergency room. Am J Prev Med 1985; 1: 23–9

Irwin C.E.J. , Millstein S.G. , Ellen JM. Appointment-keeping behavior in adolescents: factors associated with follow-up appointment keeping. Pediatrics 1993; 92: 20–3

O'Brien G. , Lazebnik R. Telephone call reminders and attendance in an adolescent clinic. Pediatrics 1998; 101: E6

Shah S. , Peat J.K. , Mazurski E.J. Effect of peer led programme for asthma education in adolescents: cluster randomised controlled. BMJ 2001; 322: 583–5